Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Pediatric ILD (START/STOP)
DRKS00014559Phase 2Recruiting
- Sponsor
- LMU Klinikum
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of hydroxychloroquine in interstitial lung disease (ILD) (4 arms), sponsored by LMU Klinikum. Started May 2018; status: recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on DRKS00014559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00014559.